The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.

Thanks to CRISPR, our medical specialists will soon have unprecedented control over how they treat and prevent some of our ...

Researchers from the University of Illinois have reported complementary discoveries that will improve scientists' ...

Plant biologists in China have used Crispr, the tool that has been deployed to treat sickle-cell disease, to engineer sweeter tomatoes.

Scribe reports preclinical data validating CRISPR genome editing and epigenome modifying technologies for addressing ...

Using Computers to Design Proteins Allows Researchers to Make ... artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that ...

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.

Preliminary data demonstrate that CTX112™ has the potential to provide meaningful clinical benefit with a well-tolerated safety profile using a ...

Presentations will showcase the company’s latest advances enabled by its CRISPR by Design TM approach to engineer safer and more effective in vivo genetic medicines for cardiometabolic disease ...